![Trajectories of Perioperative Serum Tumor Markers and Colorectal Cancer Outcomes: A Retrospective, Multicenter Longitudinal Cohort Study - eBioMedicine Trajectories of Perioperative Serum Tumor Markers and Colorectal Cancer Outcomes: A Retrospective, Multicenter Longitudinal Cohort Study - eBioMedicine](https://www.thelancet.com/cms/asset/92fa2a4c-e9e8-42b6-be07-cb3711d901e7/gr1.jpg)
Trajectories of Perioperative Serum Tumor Markers and Colorectal Cancer Outcomes: A Retrospective, Multicenter Longitudinal Cohort Study - eBioMedicine
![Clinical significance and diagnostic value of serum NSE, CEA, CA19‑9, CA125 and CA242 levels in colorectal cancer Clinical significance and diagnostic value of serum NSE, CEA, CA19‑9, CA125 and CA242 levels in colorectal cancer](https://www.spandidos-publications.com/article_images/ol/20/1/ol-20-01-0742-g01.jpg)
Clinical significance and diagnostic value of serum NSE, CEA, CA19‑9, CA125 and CA242 levels in colorectal cancer
![Diagnosis of malignant pleural effusion with combinations of multiple tumor markers: A comparison study of five machine learning models - Yixi Zhang, Jingyuan Wang, Baosheng Liang, Hanyu Wu, Yangyu Chen, 2023 Diagnosis of malignant pleural effusion with combinations of multiple tumor markers: A comparison study of five machine learning models - Yixi Zhang, Jingyuan Wang, Baosheng Liang, Hanyu Wu, Yangyu Chen, 2023](https://journals.sagepub.com/cms/10.1177/03936155231158125/asset/images/large/10.1177_03936155231158125-fig2.jpeg)
Diagnosis of malignant pleural effusion with combinations of multiple tumor markers: A comparison study of five machine learning models - Yixi Zhang, Jingyuan Wang, Baosheng Liang, Hanyu Wu, Yangyu Chen, 2023
![Management of Patients with Normal Cystoscopy but Positive Cytology or Urine Markers - ScienceDirect Management of Patients with Normal Cystoscopy but Positive Cytology or Urine Markers - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2588931119300987-gr1.jpg)
Management of Patients with Normal Cystoscopy but Positive Cytology or Urine Markers - ScienceDirect
![The utility of the tumor markers CA15.3, CEA, CA-125 and CA19.9 in metastatic breast cancer | Breast Cancer Management The utility of the tumor markers CA15.3, CEA, CA-125 and CA19.9 in metastatic breast cancer | Breast Cancer Management](https://www.futuremedicine.com/cms/10.2217/bmt-2020-0015/asset/images/medium/figure2.gif)
The utility of the tumor markers CA15.3, CEA, CA-125 and CA19.9 in metastatic breast cancer | Breast Cancer Management
Serum desâ•'gammaâ•'carboxyprothrombin concentration determined by the avidinâ•'biotin complex method in small he
![The prognostic value of serum CA 19-9 for patients with advanced lung adenocarcinoma | BMC Cancer | Full Text The prognostic value of serum CA 19-9 for patients with advanced lung adenocarcinoma | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-016-2897-6/MediaObjects/12885_2016_2897_Fig2_HTML.gif)
The prognostic value of serum CA 19-9 for patients with advanced lung adenocarcinoma | BMC Cancer | Full Text
![Tumour immune microenvironment biomarkers predicting cytotoxic chemotherapy efficacy in colorectal cancer | Journal of Clinical Pathology Tumour immune microenvironment biomarkers predicting cytotoxic chemotherapy efficacy in colorectal cancer | Journal of Clinical Pathology](https://jcp.bmj.com/content/jclinpath/74/10/625/F2.large.jpg)
Tumour immune microenvironment biomarkers predicting cytotoxic chemotherapy efficacy in colorectal cancer | Journal of Clinical Pathology
![Diagnostics | Free Full-Text | The Potential Role of MUC16 (CA125) Biomarker in Lung Cancer: A Magic Biomarker but with Adversity Diagnostics | Free Full-Text | The Potential Role of MUC16 (CA125) Biomarker in Lung Cancer: A Magic Biomarker but with Adversity](https://pub.mdpi-res.com/diagnostics/diagnostics-12-02985/article_deploy/html/images/diagnostics-12-02985-g001.png?1669713043)
Diagnostics | Free Full-Text | The Potential Role of MUC16 (CA125) Biomarker in Lung Cancer: A Magic Biomarker but with Adversity
![Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics](https://pubs.rsna.org/cms/10.1148/rg.2021210005/asset/images/medium/rg.2021210005.fig13.gif)
Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics
![What are liquid biopsies? Understanding ctDNA and circulating tumor cells | MD Anderson Cancer Center What are liquid biopsies? Understanding ctDNA and circulating tumor cells | MD Anderson Cancer Center](https://www.mdanderson.org/images/publications/cancerwise/Generics/circulating-tumor-cell.jpg)
What are liquid biopsies? Understanding ctDNA and circulating tumor cells | MD Anderson Cancer Center
![Trends in liver function tests: a comparison with serum tumor markers in metastatic uveal melanoma (part 2). | Semantic Scholar Trends in liver function tests: a comparison with serum tumor markers in metastatic uveal melanoma (part 2). | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/49d4bbff5f271199bc084ebe9669dc1fe5d22b2b/3-TableI-1.png)
Trends in liver function tests: a comparison with serum tumor markers in metastatic uveal melanoma (part 2). | Semantic Scholar
![Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics](https://pubs.rsna.org/cms/10.1148/rg.2021210005/asset/images/medium/rg.2021210005.va.gif)